We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
There is “little appetite on the part of donors to establish new global funding instruments specifically to address antimicrobial resistance,” the WHO says. Read More
The Department of Justice has entered the legal battle against Mallinckrodt over HP Acthar gel, joining a pair of whistleblower lawsuits that allege a company the drugmaker acquired bribed doctors to push the drug among other unlawful tactics. Read More
Bids are due by the end of the month that FDA officials hope will revolutionize the agency’s Sentinel database, CDER Director Janet Woodcock told a standing-room only crowd at the Food and Drug Law Institute’s annual meeting in Washington, D.C, on Thursday. Read More
Acting FDA Commissioner Ned Sharpless had his coming-out party on Thursday at the Food and Drug Law Institute’s annual conference in Washington, D.C., where he reassured participants that, although there may be a new belle, the ball will go on as planned. Read More
Prescription drug costs would likely have a small impact on federal spending under a single-payer system but a national health system might have the unintended consequence of forcing drugmakers to stop taking risks on new medicines, the Congressional Budget Office says in a new analysis released Wednesday. Read More